Clinical application of fish-oil intravenous lipid emulsion in adult home parenteral nutrition patients.

Manpreet S MundiSara L BonnesBradley R SalonenM Molly McMahonRobert G MartindaleRyan T Hurt

Published in: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (2020)

Current case presentations and review of literature support the use of FO ILE to increase ω-3 PUFAs in patients with IFALD refractory to MO ILE. Additional research is necessary to delineate the dose of FO ILE necessary to achieve benefit.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
prognostic factors
fatty acid
high dose
patient reported outcomes